Case Study

GPEx® Expression System Increased Production of Pritumumab in a CHO Cell Line

Format: PDF file | Document type: Case Study | Promoted Content

This Case Study has been written by Catalent Pharma Solutions , and any views and opinions expressed do not necessarily reflect those of www.biopharma-reporter.com

GPEx® Expression System Increased Production of Pritumumab in a CHO Cell Line

In this case study poster presentation, the GPEx®​  mammalian expression technology was used for the production of Pritumumab and compared to human hybridoma cells.

This poster will demonstrate:

  • Master cell bank candidate was developed in 5 months from the start of the project
  • GPEx®​  consistently generated genetically stable higher expressing cell lines
  • The GPEx®​ cell lines demonstrated higher rates ( 20 to 80 fold higher) than the human hybridoma system
  • Increased productivity utilizing the GPEX®​  system to move projects into clinical trials faster